ダウンロード数: 260
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
35_231.pdf | 443.63 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 神波, 照夫 | ja |
dc.contributor.author | 若林, 賢彦 | ja |
dc.contributor.author | 金, 哲將 | ja |
dc.contributor.author | 石田, 章 | ja |
dc.contributor.author | 新井, 豊 | ja |
dc.contributor.author | 小西, 平 | ja |
dc.contributor.author | 朴, 勺 | ja |
dc.contributor.author | 竹内, 秀雄 | ja |
dc.contributor.author | 友吉, 唯夫 | ja |
dc.contributor.author | 渡辺, 仁 | ja |
dc.contributor.author | 尾松, 操 | ja |
dc.contributor.author | 山内, 民男 | ja |
dc.contributor.author | 国保, 昌紀 | ja |
dc.contributor.alternative | KONAMI, Teruo | en |
dc.contributor.alternative | WAKABAYASHI, Yoshihiko | en |
dc.contributor.alternative | KIM, Tessho | en |
dc.contributor.alternative | ISHIDA, Akira | en |
dc.contributor.alternative | ARAI, Yutaka | en |
dc.contributor.alternative | KONISHI, Taira | en |
dc.contributor.alternative | PAK, Kyun | en |
dc.contributor.alternative | TAKEUCHI, Hideo | en |
dc.contributor.alternative | TOMOYOSHI, Tadao | en |
dc.contributor.alternative | WATANABE, Jin | en |
dc.contributor.alternative | OMATSU, Misao | en |
dc.contributor.alternative | YAMAUCHI, Tamio | en |
dc.contributor.alternative | KOKUHO, Masanori | en |
dc.date.accessioned | 2010-06-01T01:47:16Z | - |
dc.date.available | 2010-06-01T01:47:16Z | - |
dc.date.issued | 1989-02 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/116442 | - |
dc.description.abstract | The VPM-CisA (vincristine (VCR), peplomycin (PLM), methotrexate (MTX), cisplatin (CDDP) and doxorubicin (ADM), regimen was used to treat 33 patients with urothelial tract tumors. Twenty-two patients had bi-dimensionally measurable disease parameters and 11 patients with locally advanced tumors were given postoperative adjuvant chemotherapy. The protocol consisted of 0.6 mg/m2 VCR on days 1 and 3, 3 mg/m2 PLM on days 1 to 4, 3 mg/m2 MTX on days 2 and 4, 35 mg/m2 CDDP on day 4, and 20 mg/m2 ADM on day 5. These doses were adjusted for each case: the above mentioned dose x [(80/(40+Age]2 +[(Karnofsky's performance status/100)2]. Of these patients, 28 (86 percent) were treated adequately, including 8 (36 per cent) who achieved a complete (2) or partial (6) remission. The mean duration of survival was 65.2 weeks for complete and partial responders, and 48.8 weeks for non-responders, which was not a statistically significant difference. Of 11, who were given post-operative adjuvant chemotherapy (mean observation period: 83.5 weeks) 9 were alive without evidence of disease, 1 had a recurrence 8 months after first chemotherapy, 1 died due to pulmonary and liver metastasis 2 years after the chemotherapy. Toxicity included mild myelosupression, moderate anorexia, vomiting, and severe gastric ulcer, pulmonary fibrosis. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.subject | Combination chemotherapy | en |
dc.subject | Urothelial cancer | en |
dc.subject.ndc | 494.9 | - |
dc.title | 尿路上皮癌に対するVincristine, Peplomycin,Methotrexate, cis-Diamminedichloroplatinum (2),Adriamycin併用療法(VPM-CisA療法) | ja |
dc.title.alternative | Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 35 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 231 | - |
dc.identifier.epage | 237 | - |
dc.textversion | publisher | - |
dc.sortkey | 05 | - |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 滋賀医科大学医学部泌尿器科学教室 | ja |
dc.address | 郡立高島病院泌尿器科 | ja |
dc.address | 宇治徳洲会病院泌尿器科 | ja |
dc.address | 癌研究所付属病院 | ja |
dc.address | 癌研究所付属病院 | ja |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | the Department of Urology, Shiga University of Medical Science | en |
dc.address.alternative | Urology Division, Takashima Country Hospital | en |
dc.address.alternative | Urology Division, Uji Tokushukai Hospital | en |
dc.address.alternative | the Department of Urology, Cancer Institute Hospital | en |
dc.address.alternative | the Department of Urology, Cancer Institute Hospital | en |
dc.identifier.pmid | 2472048 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.35 No.2 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。